Cardinal Health Inc (CAH) Sec Form 10Q
Cardinal Health Inc (NYSE: CAH) Sec Form 10Q
22 articles, transcripts, and reports
Cardinal Health Inc (NYSE: CAH) Sec Form 10Q
Cardinal Health Inc (NYSE: CAH) Sec Form 8K
Cardinal Health Inc (NYSE: CAH) Q1 2022 Earnings Call dated Nov. 09, 2021 Corporate Participants: Kevin Moran — Vice President of Investor Relations Michael Kaufmann…
Cardinal Health Inc (NYSE: CAH) Q2 2025 Earnings Call dated Jan. 30, 2025 Corporate Participants: Matt Sims — Vice President, Investor Relations Jason Hollar —…
Cardinal Health Inc (NYSE: CAH) Q3 2025 Earnings Call dated May. 01, 2025 Corporate Participants: Matt Sims — Vice President, Investor Relations Jason Hollar —…
Cardinal Health Inc (NYSE: CAH) Q4 2025 Earnings Call dated Aug. 12, 2025 Corporate Participants: Matt Sims — Vice President, Investor Relations Jason Hollar —…
Cardinal Health Inc (NYSE: CAH) Q1 2026 Earnings Call dated Oct. 30, 2025 Corporate Participants: Matt Sims — Vice President, Head of Investor Relations and…
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the fourth quarter of 2024. Fourth…
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues increased 13% year-over-year…
Cardinal Health Inc (NYSE: CAH) Q2 2023 earnings call dated Feb. 02, 2023 Corporate Participants: Kevin Moran — Vice President of Investor Relations Jason Hollar — Chief Executive Officer Aaron…